# OnCo record mercaptopurine (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mercaptopurine/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mercaptopurine" ;
  schema:name "Mercaptopurine"@en ;
  schema:alternateName "6-MP"@en, "Xaluprine"@en, "Purinethol / Purixan" ;
  schema:description "Mercaptopurine is a daily tablet, or a liquid for children, that keeps acute lymphoblastic leukaemia in remission during the long maintenance phase of treatment."@en ;
  schema:url <https://onco.cc/drugs/mercaptopurine/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Mercaptopurine> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=mercaptopurine>, <https://www.cancer.gov/about-cancer/treatment/drugs/mercaptopurine>, <https://www.ema.europa.eu/en/medicines/human/EPAR/xaluprine> ;
  onco:status "approved" ;
  onco:tag "nci-list", "generic" ;
  onco:modality "Thiopurine antimetabolite" ;
  onco:approval "US 1953: Acute lymphoblastic leukaemia, combination maintenance therapy", "US 2014: Oral suspension for ALL maintenance (Purixan)", "EU 2012: ALL in adults, adolescents and children (Xaluprine oral suspension)" ;
  onco:related <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/drugs/thioguanine/> ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:trials <https://onco.cc/trials/nct03150693/>, <https://onco.cc/trials/nct02883049/>, <https://onco.cc/trials/nct00557193/> .